Beconase Aq Nasal Spray, Suspension 42Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Beconase AQ: Nasal spray, suspension (42mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Beconase AQ 42mcg/act Spray

What is this Medicine?

BECLOMETHASONE (be kloe METH a sone) is a corticosteroid. It helps decrease inflammation in your nose. This medicine is used to treat the symptoms of allergies like sneezing, itching, and runny or stuffy nose. This medicine is also used to prevent the return of nasal polyps.

CVS Pharmacy Patient Statistics for Beconase AQ: Nasal spray, suspension(42mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Beconase AQ 42mcg/actuation Nasal Spray

NDC: 001730388
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Vasomotor Rhinitis, Allergic Rhinitis, Nasal Polyps

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Beconase AQ 42mcg/actuation Nasal Spray

Reported Side Effects for Beconase AQ 42mcg/actuation Nasal Spray

Nasal Septum Perforation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<9.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
<11.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
2.0-8.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Sneezing Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Nasal Irritation Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Beconase AQ

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5